Bioinformatic and functional analysis of TGFBR1 polymorphisms

Pharmacogenetics and Genomics

Volumn 19, Issue 4, 2009, Pages 249-259

  Schirmer, Markus A ^a,b   Hoffmann, Arne O ^a   Campean, Radu ^a   Janke, Jörg H ^a   Zidek, Laura M ^a   Hoffmann, Marion ^a   Kruse, Moritz ^a   Sehrt, Daniel ^a   Tzvetkov, Mladen V ^a   Rave Fränk, Margret ^a   Bröckmoller, Jürgen ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

Irradiation; Polymorphism; SMAD3; SMAD7; TGFBR1*6A; Transforming growth factor ; Transforming growth factor receptor 1

Indexed keywords

LIGAND; MESSENGER RNA; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1;

ALLELE; ARTICLE; BIOINFORMATICS; CANCER SUSCEPTIBILITY; CELL VIABILITY; CYTOTOXICITY; DOWN REGULATION; FLOW CYTOMETRY; GENE; GENE DELETION; GENE EXPRESSION PROFILING; GENETIC SELECTION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; MALE; MONONUCLEAR CELL; NORMAL HUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RADIATION EXPOSURE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TGFBR1 6A GENE; UPREGULATION; X IRRADIATION;

ADULT; CELL SURVIVAL; CELLS, CULTURED; COMPUTATIONAL BIOLOGY; GENE EXPRESSION REGULATION; GENETIC VARIATION; HAPLOTYPES; HUMANS; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RECOMBINANT PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; X-RAYS; YOUNG ADULT;

EID: 63849172642     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32831cb5a7     Document Type: Article

References (37)

1. Leask A, Abraham DJ. TGF-beta signaling and the fibrotic response. FASEB J 2004; 18:816-827.
2. Martin M, Vozenin MC, Gault N, Creohet F, Pfarr CM, Lefaix JL. Coactivation of AP-1 activity and TGF-beta1 gene expression in the stress response of normal skin cells to ionizing radiation. Oncogene 1997; 15:981-989.
3. Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, et al. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 2000; 47:1033-1042.
4. Randall K, Coggle JE. Long-term expression of transforming growth factor TGF beta 1 in mouse skin after localized beta-irradiation. Int J Radiat Biol 1996; 70:351-360.
5. Fu XL, Huang H, Bentel G, Clough R, Jirtle RL, Kong FM, et al. Predicting the risk of symptomatic radiation-induced lung injury using both the physical and biologic parameters V(30) and transforming growth factor beta. Int J Radiat Oncol Biol Phys 2001; 50:899-908.
6. De Jaeger K, Seppenwoolde Y, Kampinga HH, Boersma U, Belderbos JS, Lebesque JV. Significance of plasma transforming growth factor-beta levels in radiotherapy for non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2004; 58:1378-1387.
7. Xavier S, Piek E, Fujii M, Javelaud D, Mauviel A, Flanders KC, et al. Amelioration of radiation-induced fibrosis: inhibition of transforming growth factor-beta signaling by halofuginone. J Biol Chem 2004; 279:15167-15176.
8. Mauduit C, Siah A, Foch M, Chapet O, Clippe S, Gerard JP, Benahmed M. Differential expression of growth factors in irradiated mouse testes. Int J Radiat Oncol Biol Phys 2001; 50:203-212.
9. Chung EJ, Choi SH, Shim YH, Bang YJ, Hur KC, Kim CW. Transforming growth factor-beta induces apoptosis in activated murine T cells through the activation of caspase 1 -like protease. Cell Immunol 2000; 204:46-54.
10. Bommireddy R, Saxena V, Ormsby I, Yin M, Boivin GP, Babcock GF, et al. TGF-beta 1 regulates lymphocyte homeostasis by preventing activation and subsequent apoptosis of peripheral lymphocytes. J Immunol 2003; 170:4612-4622.
11. *6A and cancer: a meta-analysis of 12 case-control studies. J Clin Oncol 2004; 22:756-758.
12. *6A really associated with increased risk of cancer? J Clin Oncol 2005; 23:7743-7744.
13. *6A variant and colorectal cancer risk. Clin Cancer Res 2007; 13:3748-3752.
14. *6A by epithelial and stromal cells during head and neck and colon cancer development. Hum Mol Genet 2007; 16:3128-3135.
15. *6A in cancer. Jama 2005; 294:1634-1646.
16. Sabeti PC, Reich DE, Higgins JM, Levine HZ, Richter DJ, Schaffner SF, et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 2002; 419:832-837.
17. Sabeti PC, Walsh E, Schaffner SF, Varilly P, Fry B, Hutcheson HB, et al. The case for selection at CCR5-Delta32. PLoS Biol 2005; 3:e378.
18. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001; 68:978-989.
19. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science 2002; 296:2225-2229.
20. Nakao A, Afrakhte M, Moren A, Nakayama T, Christian JL, Heuchel R, et al. Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 1997; 389:631-635.
21. Brunak S, Engelbrecht J, Knudsen S. Prediction of human mRNA donor and acceptor sites from the DNA sequence. J Mol Biol 1999; 220:49-65.
22. Kunzmann S, Wohlfahrt JG, Itoh S, Asao H, Komada M, Akdis CA, et al. SARA and Hgs attenuate susceptibility to TGF-beta1 -mediated Tcell suppression. FASEB J 2003; 17:194-202.
23. Yanagisawa K, Osada H, Masuda A, Kondo M, Saito T, Yatabe Y, et al. Induction of apoptosis by Smad3 and down-regulation of Smad3 expression in response to TGF-beta in human normal lung epithelial cells. Oncogene 1998; 17:1743-1747.
24. Zhao Y, Geverd DA. Regulation of Smad3 expression in bleomycin-induced pulmonary fibrosis: a negative feedback loop of TGF-beta signaling. Biochem Biophys Res Commun 2002; 294:319-323.
25. Zhang M, Fraser D, Phillips A. ERK, p38, and Smad signaling pathways differentially regulate transforming growth factor-betal autoinduction in proximal tubular epithelial cells. Am J Pathol 2006; 169:1282- 1293.
26. Ross KR, Corey DA, Dunn JM, Kelley TJ. SMAD3 expression is regulated by mitogen-activated protein kinase kinase-1 in epithelial and smooth muscle cells. Cell Signal 2007; 19:923-931.
27. Holmstrom TH, Schmitz I, Soderstrom TS, Poukkula M, Johnson VL, Chow SC, et al. MAPK/ERK signaling in activated T cells inhibits CD95/ Fas-mediated apoptosis downstream of DISC assembly. Embo J 2000; 19:5418-5428.
28. Saxena V, Lienesch DW, Zhou M, Bommireddy R, Azhar M, Doetschman T, et al. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol 2008; 180:1903- 1912.
29. Town T, Laouar Y, Pittenger C, Mori T, Szekely CA, Tan J, et al. Blocking TG F- beta-Smad2/3 innate immune signaling mitigates Alzheimer-like pathology. Nat Med 2008; 14:681-687.
30. Flanders KC. Smad3 as a mediator of the fibrotic response. Int J Exp Pathol 2004; 85:47-64.
31. Jen KY, Cheung VG. Transcriptional response of lymphoblastoid cells to ionizing radiation. Genome Res 2003; 13:2092-2100.
32. Choi SG, Yi Y, Kim YS, Kato M, Chang J, Chung HW, et al. A novel ets-related transcription factor, ERT/ESX/ESE-1, regulates expression of the transforming growth factor-beta type II receptor. J Biol Chem 1998; 273:110-117.
33. *6A and cancer risk: a meta-analysis of seven case-control studies. J Clin Oncol 2003; 21:3236-3243.
34. Xu Y, Pasche B. TGF-beta signaling alterations and susceptibility to colorectal cancer. Hum Mol Genet 2007; 16 (Spec no 1):R14-R20.
35. Bendtsen JD, Nielsen H, Von Heijne G, Brunak S. Improved prediction of signal peptides: SignalP 3.0. J Mol Biol 2004; 340:783-795.
36. Chen T, De Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, et al. Structural alterations of transforming growth factor-beta receptor genes in human cervical carcinoma. Int J Cancer 1999; 82:43-51.
37. Pasche B, Kolachana P, Nafa K, Satagopan J, Chen YG, Lo RS, et al. TbetaR-1(6A) is a candidate tumor susceptibility allele. Cancer Res 1999; 59:5678-5682.